Generate Donations to FCF
Shop smile.amazon.com when doing Christmas shopping – actually any time of the year – and designate FCF as the recipient of Amazon donations. FCF will get a small percentage for everything you purchase on Amazon. Prices are the same as on amazon.com so there is no cost to you and your purchases help FCF research.
Fibro community review grants for Department of Defense
Big thanks to Jenny Carroll, Jennifer Strickland and all in the FLC community who participated in the 2019 Department of Defense grant reviews. Since liver cancer has been an approved cancer for DOD funding, Fibrolamellar has been awarded over $2 million in support. So the effort is paying out in a major way. We need […]
Free treatment and clinical trial access.
Did you realize the National Cancer Institute offers free consultation, treatment and travel for fibrolamellar (FLC) patients? Dr. Tim Greten, MD spearheads the NCI’s fibrolamellar efforts and is available to speak with anyone in our community interested in learning more. Besides offering tailored treatment for each patient per consultation, there are also two clinical trials […]
October 1 was Rare Cancer Day
Tuesday October 1, 2019 was Rare Cancer Day. This year is especially important because at the Fibrolamellar Cancer Foundation (FCF) we are celebrating 10 years of bringing awareness to this disease. We are proud to have contributed nearly 8 million dollars to researching cures and treatments for this horrific disease. Despite the fact that […]
Important U of Washington study published
FLC tumors contain a unique genetic defect that fuses together portions of genes called DNAJ and PKAc. DNAJ helps fold other proteins into their correct shapes, whereas PKAc is an enzyme involved in cell communication. An FCF supported research team at the University of Washington, Seattle now report that the DNAJ-PKAc fusion additionally recruits […]
St. Jude Children’s Research Hospital and University of Tennessee co-host major fibrolamellar research collaboration summit focused on immunotherapy
The summit brought together some of the most innovative researchers, clinicians and funders serving the FLC community, including Johns Hopkins, Rush University, University of Maryland, along with co-hosts St. Jude Children’s Research Hospital and U of Tennessee and The Fibrolamellar Cancer Foundation. The meeting highlighted many of the latest discoveries in FLC immunotherapy which were […]
Collaborative research seeking therapeutic treatment
Cornell publishes fibrolamellar discovery which could serve as part of a new therapeutic approach. This study is a great example of the multi-institution collaboration strategy FCF continues to fund in our quest for curative therapies. Small molecules inside our bodies called “microRNAs” have emerged as very important players in the development of a wide variety […]
2019 FCF Scientific Conference
SAVE THE DATE: November 5-7, 2019 in Greenwich, CT. Details to follow.
Report on 2017 Scientific Conference
The distinquished Journal of Hepatocellular Carcinoma has published a report on FCF’s 2017 Scientific Conference. Authors are Drs. Ted Kastenhuber, Ghassan AbouAlfa, and John Craig who coordinated the writing and editing. FCF thanks these doctors for their time and commitment to this article. The article, which can be viewed here, is titled, “Road map for […]
Duke University Research Conversation and Facilities Tour
Dr. Anna Mae Diehl, Professor, Department of Medicine at Duke University and by Dr. Cynthia Guy, Associate Professor, Department of Pathology at Duke University Medical Center hosted an FCF event in October 2018. The event showcased the important fibrolamellar research work being conducted at this prestigious institution. It included an overview of FCF’s research mission, […]